Diagnostics Market Research Reports & Industry Analysis

The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.

New Diagnostics Industry Reports Produced by Industry Experts

To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.

What Are the Benefits of Using MarketResearch.com?

  • At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
  • We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
  • Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
  • With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
...Show More ...Show Less


Diagnostics Industry Research & Market Reports

  • Asia Cervical Cancer Screening Market, Size, Forecast 2024-2032, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

    ... billion by 2032 up from US$ 3.76 billion in 2023. This expected growth is going to be a CAGR 4.23% between 2024 and 2032. Women health and preventive medicine has been of most concern resulting ... Read More

  • Hereditary Testing

    ... at a CAGR of 6.1% over the analysis period 2023-2030. Preimplantation Genetic Diagnosis & Screening Test, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$4.6 Billion ... Read More

  • Global Radiotherapy Market (By Technology, Procedure, Application, End User, Country Analysis), Company Profiles, Market Dynamics, Trends & Recent Developments – Forecast to 2030

    ... and is predicted to reach US$ 10.27 Billion by 2030. Radiotherapy, also called radiation therapy, is a medical technique used to treat cancer and some non-cancerous conditions. This non-invasive therapy can be administered externally, known ... Read More

  • Immunofluorescence Assays

    ... at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence Assays Reagents, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.8 Billion by the end ... Read More

  • In Vitro Diagnostics

    ... by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. In Vitro Diagnostics Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and ... Read More

  • Automated Immunoassay Analyzers

    ... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the ... Read More

  • Hemostasis and Tissue Sealing Agents

    ... is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Topical Hemostat, one of the segments analyzed in the report, is expected to record a 8.4% ... Read More

  • Surgical Imaging Technologies

    ... by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Image Intensifier C-arms Technology, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$3.4 ... Read More

  • Teleradiology

    ... of 17.2% over the analysis period 2023-2030. X-ray, one of the segments analyzed in the report, is expected to record a 15.8% CAGR and reach US$5.2 Billion by the end of the analysis period. Growth ... Read More

  • Flat Panel X-Ray Detectors

    ... reach US$2.3 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Manufacturing Application, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach ... Read More

  • Microbiology Culture

    ... at a CAGR of 3.9% over the analysis period 2023-2030. Eukaryotic Culture, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.2 Billion by the end of ... Read More

  • Acute Ischemic Stroke Diagnosis and Treatment

    ... the year 2023, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Computed Tomography, one of the segments analyzed in the report, is expected to ... Read More

  • Clostridium Diagnostics

    ... at a CAGR of 14.1% over the analysis period 2023-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$9.1 Billion by the end of ... Read More

  • High-Density Multiplexed Diagnostic Assays

    ... reach US$5.5 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2023-2030. Diagnostic Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and ... Read More

  • Hybrid Operating Rooms

    ... by 2030, growing at a CAGR of 12.2% over the analysis period 2023-2030. Cardiovascular Application, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$1.2 Billion by ... Read More

  • In-Vitro Colorectal Cancer Screening Tests

    ... is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Fecal Occult Blood Test, one of the segments analyzed in the report, is expected to record ... Read More

  • Heavy Metal Testing

    ... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Arsenic Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.1 Billion by ... Read More

  • Human Papillomavirus (HPV) Testing

    ... reach US$1.8 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR ... Read More

  • Specimen Validity Testing

    ... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Specimen Validity Testing Products, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$2.9 ... Read More

  • X-Ray Photoelectron Spectroscopy

    ... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$339.2 Million by ... Read More

  • Helicobacter Pylori Diagnostics

    ... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by ... Read More

  • Japan Diagnostic Imaging Equipment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

    ... to reach USD 4.49 billion by 2029, growing at a CAGR of 4.83% during the forecast period (2024-2029). The COVID-19 outbreak significantly impacted Japan's healthcare industry as the country lacked beds to accommodate COVID-19 patients. ... Read More

  • Clinical Risk Grouping Solutions

    ... 2030, growing at a CAGR of 13.7% over the analysis period 2023-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.1 Billion ... Read More

  • Toxicology Testing Services

    ... at a CAGR of 8.4% over the analysis period 2023-2030. In Vivo Method, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$10.2 Billion by the end ... Read More

  • Medical Cyclotron

    ... CAGR of 10.4% over the analysis period 2023-2030. 16-18 MeV Cyclotron, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$317.8 Million by the end of the ... Read More

Cookie Settings